These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic stability and product consistency of rDNA-derived biologicals from mammalian cells. Bebbington CR; Lambert K Dev Biol Stand; 1994; 83():183-4. PubMed ID: 7883094 [No Abstract] [Full Text] [Related]
3. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing. Griffiths E Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093 [TBL] [Abstract][Full Text] [Related]
4. Genetic stability: an issue of product quality. Burns N Biologicals; 1993 Jun; 21(2):145-6. PubMed ID: 8297594 [No Abstract] [Full Text] [Related]
6. WHO/NIBSC workshop on genetic stability and product consistency of rDNA derived biologicals. November 23-24, 1992. Proceedings. Biologicals; 1993 Jun; 21(2):89-156. PubMed ID: 8297605 [No Abstract] [Full Text] [Related]
7. Supplement to the points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology: nucleic acid characterization and genetic stability. Biologicals; 1993 Mar; 21(1):81-3. PubMed ID: 8217122 [No Abstract] [Full Text] [Related]
8. Harmonizing viewpoints on ensuring the consistency and stability of rDNA-derived biologicals. Corran PH; Griffiths E; Robertson JS; Geisow MJ Trends Biotechnol; 1993 Mar; 11(3):77-80. PubMed ID: 7765294 [No Abstract] [Full Text] [Related]
9. Genetic and biochemical factors affecting product consistency: introduction to the issues. Seamon KB Dev Biol Stand; 1992; 76():63-7. PubMed ID: 1478357 [No Abstract] [Full Text] [Related]
10. Genetic stability and recombinant product consistency. Lubiniecki AS Dev Biol Stand; 1994; 83():3-6. PubMed ID: 7883097 [No Abstract] [Full Text] [Related]
11. Genetic stability and product consistency: EC point of view. Trouvin JH Biologicals; 1993 Jun; 21(2):155-6. PubMed ID: 8297598 [No Abstract] [Full Text] [Related]
12. Control of therapeutic goods produced by recombinant DNA technology. Breschkin A Dev Biol Stand; 1987; 67():207-11. PubMed ID: 3475226 [TBL] [Abstract][Full Text] [Related]
13. Quality control of biologicals produced by r-DNA technology. Liu DT; Gates FT; Goldman ND Dev Biol Stand; 1985; 59():161-6. PubMed ID: 4007274 [TBL] [Abstract][Full Text] [Related]
14. The quality control of biotechnology products. Federici MM Biologicals; 1994 Jun; 22(2):151-9. PubMed ID: 7917231 [No Abstract] [Full Text] [Related]
15. The control of biological medicinal products produced by recombinant DNA technology. Griffiths E Dev Biol Stand; 1985; 59():155-9. PubMed ID: 4007273 [TBL] [Abstract][Full Text] [Related]
16. Peptide mapping for detecting variants in protein products. Garnick RL Dev Biol Stand; 1992; 76():117-30. PubMed ID: 1478332 [TBL] [Abstract][Full Text] [Related]
17. Biological assays: their role in the development and quality control of recombinant biological medicinal products. Mire-Sluis AR; Gerrard T; Das RG; Padilla A; Thorpe R Biologicals; 1996 Dec; 24(4):351-62. PubMed ID: 9088552 [No Abstract] [Full Text] [Related]
18. Quality control of biologicals produced by recombinant DNA techniques. WHO consultation. WHO Consultation Bull World Health Organ; 1983; 61(6):897-911. PubMed ID: 6609009 [TBL] [Abstract][Full Text] [Related]
19. USDA licensing policy for biologicals produced by R-DNA. Espeseth DA; Shibley GP; Joseph PL; van Deusen RA; Whetstone CA Dev Biol Stand; 1985; 59():167-73. PubMed ID: 4007275 [TBL] [Abstract][Full Text] [Related]
20. Purified protein products of rDNA technology expressed in animal cell culture. Lubiniecki AS; Lupker JH Biologicals; 1994 Jun; 22(2):161-9. PubMed ID: 7522477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]